Microbiological Testing/Measurement TRIZ Cases

Hybridization capture concentrates sequencing on cancer-specific CpG regions, reducing WGBS cost while supporting sensitive cfDNA detection.

Replacing invasive cystoscopy and cytology, urine qRT-PCR measures four mRNA markers for bladder cancer detection and recurrence monitoring.

Low-DNA-input sequencing can require labor-intensive separate steps; multifunctional primers combine amplification and barcoding on a solid substrate to reduce hands-on time and contamination risk.

An α-L-fucosidase from Vibrio sp. EJY3 cleaves lactose and maltose into monosaccharides and extends maltooligosaccharides through transglycosylation.

Six linked SNP loci enable marker-assisted selection of tea plants with targeted caffeine levels, avoiding slow conventional breeding cycles.

Complex plant genomes make direct sequencing costly and inaccurate; TUMI-guided directional reads identify associated DNA sequences efficiently.

Cell beads and antibody-coupled nucleic acid barcodes preserve analyte origin for sequencing-based identification at single-cell level.

High probe density can undermine stability and uniformity; a self-assembled β-sheet oligopeptide layer anchors probes through cysteine for sensitive detection.

Differentially expressed miRNAs in blood or cyst fluid distinguish high-risk IPMNs for resection from those suitable for monitoring.

MUC5B variants and RNA or protein levels stratify pulmonary fibrosis risk, prognosis, and treatment for more personalized care.

Pre-screened primer pairs and tuned annealing conditions limit primer dimers during multi-locus PCR for downstream sequencing.

Reversibly bound divalent ions are released by pH adjustment to initiate specific, efficient amplification without pre-heating.

Specific binding partners on nanoparticles form visible halos in a gelled medium for rapid microorganism detection and isolation.

Single-locus PCR can cause false positives in complex samples; multi-locus amplicon sequencing separates biothreats from near neighbors.

Anti-CA-IX immunocapture isolates tumor-derived exosomes for quantifying tumor-related nucleic acids in biological fluids.

Alternating detected and dark extension cycles lengthen sequencing reads, reducing assembly burden while improving rare-mutation detection.

Pre-treatment biomarker profiling identifies patients likely to benefit from immune checkpoint therapy and supports personalized treatment recommendations.

Li+, betaine, inhibitory metal ions, and PEI stabilize ternary complexes while reducing free labeled components that obscure SBB detection.

ATPS pre-concentrates urine analytes before magnetic-bead binding, reducing protein and salt interference and improving diagnostic recovery.

DNA-tagged saliva simulants mimic respiratory droplets, enabling PCR tracking of airborne mobility without real pathogens.

Sequence heterogeneity can undermine HPIV assay sensitivity and specificity; targeted oligomers and hybridization improve detection and quantification.

Sulfone solvent and polyvinyl sulfonic acid create homogeneous buffers for rapid ISH with freeze-thaw and phase stability.

Retinal degeneration can outpace conventional treatment; a wearable RF-coil and electrode device uses charge-balanced stimulation to promote neuroprotection.

Restriction enzymes replace lengthy bisulfite processing, enabling quantitative DNA methylation detection in an automated qPCR workflow.

Traditional impedance sensing can miss cells; cross-electrode measurements provide label-free adhesion mapping without invasive viability impacts.

Aptamer-controlled polymerase activation and self-priming nanostructures create visual nucleic acid signals without complex PCR or LAMP equipment.

Cytoplasmic PD-L1 measurement improves cancer therapy response prediction beyond conventional surface PD-L1 assessment.

An internal NAD(P) depot maintains coenzyme availability, addressing diffusion limits that reduce sensitivity and shorten implantable sensor life.

Tagged TFO hybridization and sandwich capture quantify intact protein-polynucleotide conjugates in serum and tissue homogenates.

Targeted SNP panels quantify FMD and AAA risk in family members, supporting personalized surveillance and symptom management.

RNA-Seq-identified A-to-I editing markers and machine learning replace subjective assessment with quantitative blood-based depression diagnosis.

Quantify CD8+ T-cell subsets in non-invasive samples and apply machine learning to predict prognosis and anticancer treatment response.

Separate chromogenic reagents hinder miniaturization; an integrated DA-67 composition supports low-H2O2 color response in 1,5-AG quantification.

Optical readouts make amplification diagnostics costly and cumbersome; MIM nanogap electrodes use current changes for early detection.

A cleavable-linker capture surface uses barcode sequences to connect single-cell images with molecular data and reduce analysis costs.

Modular hollow chambers and screens support pollutant or organism studies while preserving oxygenated aquatic conditions for repeated sampling.

Separate CpG and TpG primers improve methylated and unmethylated sequence recognition for sensitive detection in trace biological samples.

PCR, qPCR, FISH, or microarray testing detects Met amplification before therapy to identify patients likely to respond to Met-targeted drugs.

Molecular barcodes and targeted amplification phase distant or intronic allelic variants for accurate genetic analysis and patient stratification.

Single complexes carrying multiple fluorophores address weak SBS signals by increasing fluorescence intensity and sequencing sensitivity.

Enzymes transfer hydrogen from biomarkers to perovskite nickelate, changing resistance for selective sensing at body temperature without external energy.

Targeted miR-214 and miR-34c measurement predicts neurodegenerative disease progression through NCKAP1-related microglial regulation.

Differentially methylated CpG sites in low-background regions support cancer signature detection with less than 20 mL of sample.

Secretory signal peptides and optimized luciferases improve brightness and stability while reducing cellular toxicity in high-throughput drug screening.

Selected microRNA biomarkers, reference sequences, and qPCR transcriptome analysis enable earlier identification of women at risk of preterm birth.

Biomarker expression changes before and after MitoQ or SKQ1 treatment help identify breast cancers likely to respond.

Graphene sensors measure current as DNA/carbon nanotube hybrids cross a nanofluidic chip, reducing motion-induced noise and improving base-composition accuracy.

A surfactant, protease, chelating agent, and buffer inactivate viral particles and enable nucleic acid detection without extraction.

Stochastic binding destabilizes fluorescent read-outs; click-chemistry coupling stabilizes nucleotide retention and supports longer sequence reads.

Chimeric polyamides bind CAG or CTG repeats and recruit regulatory molecules to modulate target-gene expression and reduce defective mRNA production.